Chemotherapy
-
Subject Areas on Research
- ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
- Chemotherapy at the End of Life (EOL) for Patients with Lung Cancer within the VA System
- Clinical characteristics and treatment of malignant brainstem gliomas in elderly patients.
- Comparison of Dietary. and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405
- Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab.
- Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
- INDUCTION CHEMORADIOTHERAPY IS NOT SUPERIOR TO INDUCTION CHEMOTHERAPY ALONE IN PATIENTS WITH STAGE IIIA(N2) NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
- Long-Term Survival after Surgery for Pathologic N1 and N2 Small Cell Lung Cancer: A Comparison with Nonoperative Management
- Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
- Part I: testicular cancer--management of early disease.
- Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)
- Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial
- Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials
- Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy
- RINDOPEPIMUT Anti-EGFRvIII Peptide Vaccine Oncolytic
- Shedding light on prostate cancer.
- The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
- Uterine Neoplasms Clinical Practice Guidelines in Oncology
- Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.
-
Keywords of People
- Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
- Halabi, Susan, Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
- Moorman, Patricia Gripka, Professor in Community and Family Medicine, Duke Cancer Institute
- Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics
- Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Immunology